SE9700661D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE9700661D0
SE9700661D0 SE9700661A SE9700661A SE9700661D0 SE 9700661 D0 SE9700661 D0 SE 9700661D0 SE 9700661 A SE9700661 A SE 9700661A SE 9700661 A SE9700661 A SE 9700661A SE 9700661 D0 SE9700661 D0 SE 9700661D0
Authority
SE
Sweden
Prior art keywords
new compounds
prevention
substituted
formula
treatment
Prior art date
Application number
SE9700661A
Other languages
English (en)
Swedish (sv)
Inventor
Kosrat Amin
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9700661A priority Critical patent/SE9700661D0/xx
Publication of SE9700661D0 publication Critical patent/SE9700661D0/xx
Priority to ZA981134A priority patent/ZA981134B/xx
Priority to ARP980100614A priority patent/AR011134A1/es
Priority to US09/043,040 priority patent/US6265415B1/en
Priority to AT98907306T priority patent/ATE218569T1/de
Priority to TR1999/02060T priority patent/TR199902060T2/xx
Priority to CN98802784A priority patent/CN1100056C/zh
Priority to NZ336878A priority patent/NZ336878A/en
Priority to PL98335485A priority patent/PL190379B1/pl
Priority to UA99084654A priority patent/UA64741C2/uk
Priority to DK98907306T priority patent/DK0971920T3/da
Priority to DE69805787T priority patent/DE69805787T2/de
Priority to IDW990903A priority patent/ID22218A/id
Priority to ES98907306T priority patent/ES2178169T3/es
Priority to PT98907306T priority patent/PT971920E/pt
Priority to BR9807457-1A priority patent/BR9807457A/pt
Priority to PCT/SE1998/000275 priority patent/WO1998037080A1/en
Priority to CA002280008A priority patent/CA2280008A1/en
Priority to JP53654998A priority patent/JP2001512477A/ja
Priority to KR1019997007685A priority patent/KR20000075622A/ko
Priority to IL13112298A priority patent/IL131122A0/xx
Priority to SI9830239T priority patent/SI0971920T1/xx
Priority to EEP199900367A priority patent/EE04016B1/xx
Priority to TW087102208A priority patent/TW568907B/zh
Priority to HU0000720A priority patent/HUP0000720A3/hu
Priority to RU99120178/04A priority patent/RU2193036C2/ru
Priority to HK00103720.1A priority patent/HK1024248B/en
Priority to SK1099-99A priority patent/SK283903B6/sk
Priority to EP98907306A priority patent/EP0971920B1/en
Priority to CZ19993014A priority patent/CZ291681B6/cs
Priority to AU63147/98A priority patent/AU723389B2/en
Priority to MYPI98000774A priority patent/MY118822A/en
Priority to IS5148A priority patent/IS1901B/is
Priority to MXPA/A/1999/007650A priority patent/MXPA99007650A/xx
Priority to NO19994078A priority patent/NO313009B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE9700661A 1997-02-25 1997-02-25 New compounds SE9700661D0 (sv)

Priority Applications (35)

Application Number Priority Date Filing Date Title
SE9700661A SE9700661D0 (sv) 1997-02-25 1997-02-25 New compounds
ZA981134A ZA981134B (en) 1997-02-25 1998-02-11 Compounds for inhibition of gastric acid secretion
ARP980100614A AR011134A1 (es) 1997-02-25 1998-02-11 Derivados de imidazo piridina substituidos para la inhibicion de la secrecion de acido gastrico; una sal del mismo, procedimiento para su preparacion, formulacion farmaceutica que los contiene y el uso de dicho compuesto para la manufactura de un medicamento
AU63147/98A AU723389B2 (en) 1997-02-25 1998-02-17 Compounds for inhibition of gastric acid secretion
PCT/SE1998/000275 WO1998037080A1 (en) 1997-02-25 1998-02-17 Compounds for inhibition of gastric acid secretion
JP53654998A JP2001512477A (ja) 1997-02-25 1998-02-17 胃酸分泌を阻止するための化合物
TR1999/02060T TR199902060T2 (xx) 1997-02-25 1998-02-17 Gastrik asit salg�lanmas�n�n inhibisyonu i�in bile�ikler.
CN98802784A CN1100056C (zh) 1997-02-25 1998-02-17 抑制胃酸分泌的化合物
NZ336878A NZ336878A (en) 1997-02-25 1998-02-17 Imidazo pyridine compounds for inhibition of gastric acid secretion
PL98335485A PL190379B1 (pl) 1997-02-25 1998-02-17 Pochodne imidazo [1,2-a] pirydyny, sposób ich wytwarzania, ich zastosowanie oraz środek farmaceutyczny
UA99084654A UA64741C2 (uk) 1997-02-25 1998-02-17 Заміщені похідні імідазопіридину, спосіб їх одержання (варіанти), фармацевтична композиція на їх основі (варіанти), спосіб пригнічення секреції шлункової кислоти або лікування шлунково-кишкових запалювальних захворювань та спосіб лікування або профілактики станів, пов'язаних з інфікуванням helicobacter pylori слизової оболонки шлунку
DK98907306T DK0971920T3 (da) 1997-02-25 1998-02-17 Forbindelser til inhibition af mavesyresekretion
DE69805787T DE69805787T2 (de) 1997-02-25 1998-02-17 Verbindungen zur hemmung der magensäuresekretion
IDW990903A ID22218A (id) 1997-02-25 1998-02-17 Senyawa-senyawa penghambat sekresi asam lambung
ES98907306T ES2178169T3 (es) 1997-02-25 1998-02-17 Compuestos para la inhibicion de la secrecion de acido gastrico.
PT98907306T PT971920E (pt) 1997-02-25 1998-02-17 Compostos para a inibicao da secrecao de acido gastrico
BR9807457-1A BR9807457A (pt) 1997-02-25 1998-02-17 Composto, sal de hidrocloreto, formulação farmacêutica, uso de um composto, e, processos para a preparação de um composto, para a inibição da secreção de ácido gástrico, para o tratamento de doenças inflamatórias gastrointestinais e para o tratamento ou profilaxia de condições que envolvem infecção por helicobacter pylori da mucosa gástrica humana.
US09/043,040 US6265415B1 (en) 1997-02-25 1998-02-17 Compounds for inhibition of gastric acid secretion
CA002280008A CA2280008A1 (en) 1997-02-25 1998-02-17 Compounds for inhibition of gastric acid secretion
AT98907306T ATE218569T1 (de) 1997-02-25 1998-02-17 Verbindungen zur hemmung der magensäuresekretion
KR1019997007685A KR20000075622A (ko) 1997-02-25 1998-02-17 위산 분비 억제용 화합물
IL13112298A IL131122A0 (en) 1997-02-25 1998-02-17 Compounds for inhibition of gastric acid secretion
SI9830239T SI0971920T1 (en) 1997-02-25 1998-02-17 Compounds for inhibition of gastric acid secretion
EEP199900367A EE04016B1 (et) 1997-02-25 1998-02-17 Ühendid maohappesekretsiooni inhibeerimiseks
TW087102208A TW568907B (en) 1997-02-25 1998-02-17 Imidazo pyridine derivatives for inhibition of gastric acid secretion
HU0000720A HUP0000720A3 (en) 1997-02-25 1998-02-17 Imidazo [1,2-a] pyridine derivatives, process for their preparation, pharmaceutical formulation containing them and their use
RU99120178/04A RU2193036C2 (ru) 1997-02-25 1998-02-17 Производные имидазо[1,2-а]пиридина, способы их получения, фармацевтический препарат на их основе, способ ингибирования секреции желудочной кислоты, способ лечения желудочно-кишечных воспалительных заболеваний и способ лечения состояний, в которые вовлечено инфицирование h.pylori
HK00103720.1A HK1024248B (en) 1997-02-25 1998-02-17 Compounds for inhibition of gastric acid secretion
SK1099-99A SK283903B6 (sk) 1997-02-25 1998-02-17 Substituované imidazopyridínové deriváty na inhibíciu sekrécie žalúdočnej kyseliny, spôsob ich prípravy, farmaceutické kompozície s ich obsahom a ich použitie
EP98907306A EP0971920B1 (en) 1997-02-25 1998-02-17 Compounds for inhibition of gastric acid secretion
CZ19993014A CZ291681B6 (cs) 1997-02-25 1998-02-17 Imidazopyridinový derivát, způsob jeho přípravy a použití a farmaceutický prostředek s jeho obsahem
MYPI98000774A MY118822A (en) 1997-02-25 1998-02-23 Compounds for inhibition of gastric acid secretion
IS5148A IS1901B (is) 1997-02-25 1999-08-05 Efnasambönd til að hindra magasýruseytrun
MXPA/A/1999/007650A MXPA99007650A (en) 1997-02-25 1999-08-18 Compounds for inhibition of gastric acid secretion
NO19994078A NO313009B1 (no) 1997-02-25 1999-08-24 Forbindelser for inhibering av mavesyresekresjon, farmasöytisk formulering inneholdende slike forbindelser, deresanvendelse og fremgangsmåte for deres fremstilling

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9700661A SE9700661D0 (sv) 1997-02-25 1997-02-25 New compounds

Publications (1)

Publication Number Publication Date
SE9700661D0 true SE9700661D0 (sv) 1997-02-25

Family

ID=20405920

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9700661A SE9700661D0 (sv) 1997-02-25 1997-02-25 New compounds

Country Status (32)

Country Link
US (1) US6265415B1 (enExample)
EP (1) EP0971920B1 (enExample)
JP (1) JP2001512477A (enExample)
KR (1) KR20000075622A (enExample)
CN (1) CN1100056C (enExample)
AR (1) AR011134A1 (enExample)
AT (1) ATE218569T1 (enExample)
AU (1) AU723389B2 (enExample)
BR (1) BR9807457A (enExample)
CA (1) CA2280008A1 (enExample)
CZ (1) CZ291681B6 (enExample)
DE (1) DE69805787T2 (enExample)
DK (1) DK0971920T3 (enExample)
EE (1) EE04016B1 (enExample)
ES (1) ES2178169T3 (enExample)
HU (1) HUP0000720A3 (enExample)
ID (1) ID22218A (enExample)
IL (1) IL131122A0 (enExample)
IS (1) IS1901B (enExample)
MY (1) MY118822A (enExample)
NO (1) NO313009B1 (enExample)
NZ (1) NZ336878A (enExample)
PL (1) PL190379B1 (enExample)
PT (1) PT971920E (enExample)
RU (1) RU2193036C2 (enExample)
SE (1) SE9700661D0 (enExample)
SK (1) SK283903B6 (enExample)
TR (1) TR199902060T2 (enExample)
TW (1) TW568907B (enExample)
UA (1) UA64741C2 (enExample)
WO (1) WO1998037080A1 (enExample)
ZA (1) ZA981134B (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
JPH10502365A (ja) * 1994-07-01 1998-03-03 リカン・リミテッド ヘリコバクタータンパク質およびワクチン
GB2324093A (en) * 1996-01-04 1998-10-14 Rican Limited Helicobacter pylori bacterioferritin
SE9602286D0 (sv) 1996-06-10 1996-06-10 Astra Ab New compounds
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
DE10001037C1 (de) * 2000-01-13 2001-12-13 Byk Gulden Lomberg Chem Fab Verfahren und Zwischenprodukte zur Herstellung von Imidazopyridinen
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
EP1423142A1 (en) * 2001-08-31 2004-06-02 Chiron SRL. Helicobacter pylori vaccination with a combination of caga, vaca and nap proteins
DE10145457A1 (de) 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
CA2499639C (en) 2002-09-19 2011-11-08 Schering Corporation Imidazopyridines as cyclin dependent kinase inhibitors
DK1603570T5 (da) * 2003-02-26 2013-12-09 Sugen Inc Aminoheteroarylforbindelser som proteinkinaseinhibitorer
ES2335498T3 (es) 2003-03-10 2010-03-29 Nycomed Gmbh Nuevo proceso para la preparacion de reflumilast.
SE0301904D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
WO2005026164A1 (en) * 2003-09-18 2005-03-24 Altana Pharma Ag Pharmacologically active imidazo[4,5-c]pyridines
CA2544325A1 (en) 2003-11-03 2005-05-12 Astrazeneca Ab Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux
SE0303451D0 (sv) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
TW200606163A (en) * 2004-04-22 2006-02-16 Eisai Co Ltd Imidazopyridine compound
ATE527258T1 (de) * 2004-07-28 2011-10-15 Takeda Pharmaceutical Pyrroloä2,3-cüpyridinverbindung, verfahren zu deren herstellung und anwendung
KR100958829B1 (ko) 2004-09-03 2010-05-25 주식회사유한양행 피롤로[2,3-ｃ]피리딘 유도체 및 그의 제조방법
EP1784402B1 (en) 2004-09-03 2011-08-03 Yuhan Corporation PYRROLO[3,2-c]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF
MX2007002219A (es) * 2004-09-03 2007-05-04 Yuhan Corp Derivados de pirrolo [3,2-b ] piridina y procesos para su preparacion.
KR101068355B1 (ko) * 2005-03-09 2011-09-28 주식회사유한양행 신규의 이미다조[1,2-ａ]피리딘 유도체 및 그의 제조방법
EP2258350B1 (en) * 2005-03-16 2014-12-24 Takeda GmbH Taste masked dosage form containing roflumilast
WO2006100119A1 (en) * 2005-03-24 2006-09-28 Glaxo Group Limited Derivatives of imidazo (1,2-a) pyridine useful as medicaments for treating gastrointestinal diseases
US7825137B2 (en) 2005-12-05 2010-11-02 Pfizer Inc. Method of treating abnormal cell growth
DK1963302T3 (da) 2005-12-05 2013-04-02 Pfizer Prod Inc Polymorfer af en C-MET/HGFR-inhibitor
FR2903107B1 (fr) * 2006-07-03 2008-08-22 Sanofi Aventis Sa Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique
EP2496578A4 (en) * 2009-11-05 2013-08-21 Univ Notre Dame Du Lac IMIDAZO [1,2-A] PYRIDINE COMPOUNDS, THEIR SYNTHESIS AND METHODS OF USE THEREOF
EA201391769A1 (ru) 2011-05-30 2014-04-30 Астеллас Фарма Инк. Имидазопиридиновые соединения
JP6056872B2 (ja) * 2012-11-30 2017-01-11 アステラス製薬株式会社 イミダゾピリジン化合物
CN120117960A (zh) * 2025-05-12 2025-06-10 天津全和诚科技有限责任公司 一种杂质化合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
HU201551B (en) * 1988-02-03 1990-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 4-oxo-4h-pyrido(1,2-a)pyrimidine-3-carboxylic acid amide derivatives and pharmaceutical compositions comprising same

Also Published As

Publication number Publication date
IS1901B (is) 2003-11-20
CZ301499A3 (cs) 2000-02-16
AR011134A1 (es) 2000-08-02
CZ291681B6 (cs) 2003-04-16
UA64741C2 (uk) 2004-03-15
SK109999A3 (en) 2000-01-18
PL190379B1 (pl) 2005-12-30
AU723389B2 (en) 2000-08-24
DK0971920T3 (da) 2002-09-16
EE9900367A (et) 2000-04-17
BR9807457A (pt) 2000-04-25
EE04016B1 (et) 2003-04-15
DE69805787T2 (de) 2003-01-02
IS5148A (is) 1999-08-05
CN1100056C (zh) 2003-01-29
CA2280008A1 (en) 1998-08-27
AU6314798A (en) 1998-09-09
TW568907B (en) 2004-01-01
DE69805787D1 (de) 2002-07-11
SK283903B6 (sk) 2004-04-06
PT971920E (pt) 2002-11-29
JP2001512477A (ja) 2001-08-21
TR199902060T2 (xx) 2000-02-21
ES2178169T3 (es) 2002-12-16
NO994078L (no) 1999-08-24
NO313009B1 (no) 2002-07-29
MX9907650A (es) 2002-12-13
HUP0000720A2 (hu) 2000-10-28
EP0971920B1 (en) 2002-06-05
RU2193036C2 (ru) 2002-11-20
HUP0000720A3 (en) 2001-01-29
WO1998037080A1 (en) 1998-08-27
EP0971920A1 (en) 2000-01-19
CN1248257A (zh) 2000-03-22
NZ336878A (en) 2001-05-25
MY118822A (en) 2005-01-31
IL131122A0 (en) 2001-01-28
KR20000075622A (ko) 2000-12-26
ZA981134B (en) 1998-08-25
ID22218A (id) 1999-09-16
PL335485A1 (en) 2000-04-25
HK1024248A1 (en) 2000-10-05
NO994078D0 (no) 1999-08-24
ATE218569T1 (de) 2002-06-15
US6265415B1 (en) 2001-07-24

Similar Documents

Publication Publication Date Title
SE9700661D0 (sv) New compounds
SE9801526D0 (sv) New compounds
SE9704404D0 (sv) New compounds
SE9602286D0 (sv) New compounds
SE9401197D0 (sv) Active compounds
SE9802794D0 (sv) New compounds
SE0102808D0 (sv) New compounds
DE69723863D1 (de) Chinoline und deren therapeutische verwendung
MY121387A (en) Imidazo[1,2-a]pyridine derivatives for the treatment of gastrointestinal diseases
ATE332302T1 (de) Alkylierte imidazopyridinderivate
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
TR199801903A2 (xx) Sulfonamid ikameli ve bunlar� i�eren farmakolojik bile�imler.
ATE196134T1 (de) Substituierte chinolinderivate, und ihre verwendung als inhibitoren der magensekretion
SE0301905D0 (sv) Novel imidazopyridine compound I with therapeutic effect
TW200503702A (en) Novel imidazopyridine compound ii with therapeutic effect
SE0301903D0 (sv) Novel imidazopyridine compound III with therapeutic effect
MX9704136A (es) Compuestos para la inhibicion de la secrecion de acido gastrico.